SCHEMBL895574

SCHEMBL895574

O=C(O)c1cc2ccccc2c(-c2cccc3ccccc23)c1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.55
WDR5 P61964 1/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
MCL1 Q07820 1/20 0.52
ACMSD Q8TDX5 1/20 0.52
ALDH1A1 P00352 3/20 0.51
HPGD P15428 3/20 0.51
KDM4E B2RXH2 2/20 0.51
NR4A1 P22736 1/20 0.51
NR4A2 P43354 1/20 0.51
NR4A3 Q92570 1/20 0.51
CYP1A2 P05177 1/20 0.51
GLA P06280 1/20 0.51
CYP2C19 P33261 1/20 0.51
HSD17B10 Q99714 1/20 0.51
CDC25B P30305 2/20 0.50
GPR84 Q9NQS5 1/20 0.47
GPR35 Q9HC97 2/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29450064 1.00 SOS1 (0.55) SOS1WDR5MEN1KMT2AMCL1
SCHEMBL28244788 0.88 MCL1 (0.48) SOS1WDR5MEN1KMT2AMCL1
SCHEMBL9516045 0.87 ALDH1A1 (0.62) SOS1WDR5MEN1KMT2AALDH1A1
SCHEMBL25176935 0.85 KDM4E (0.49) SOS1WDR5MEN1KMT2AMCL1
SCHEMBL31628873 0.84 SOS1 (0.62) SOS1WDR5MEN1KMT2AMCL1
SCHEMBL27977392 0.82 MEN1 (0.56) SOS1WDR5MEN1KMT2AALDH1A1
SCHEMBL29458346 0.82 WDR5 (0.79) SOS1WDR5MEN1KMT2AMCL1
SCHEMBL9124028 0.82 WDR5 (0.79) SOS1WDR5MEN1KMT2AMCL1
SCHEMBL11693581 0.81 WDR5 (0.53) SOS1WDR5MEN1KMT2AMCL1
SCHEMBL1821518 0.81 MCL1 (0.55) SOS1WDR5MEN1KMT2AMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12263464-B2 Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) 2025-04-01 US claimed
CN-119409587-A Amino acid derivative of 2,2 '-binaphthyl-6, 6' -dicarboxylic acid, and preparation method and application thereof 武汉大学人民医院(湖北省人民医院) 2025-02-11 CN claimed
US-20240199653-A1 METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-06-20 US claimed
CN-115745830-B Binaphthyl dicarboxylic acid derivative, preparation method and application thereof 武汉大学人民医院(湖北省人民医院) 2024-03-29 CN claimed
CN-115745830-A Binaphthyl dicarboxylic acid derivative, and preparation method and application thereof 武汉大学人民医院(湖北省人民医院) 2023-03-07 CN claimed
CN-112973461-B Mixed matrix membrane with chiral metal organic molecular cage as filler and preparation and application thereof 上海交通大学 2021-12-28 CN claimed
CN-112973461-A Mixed matrix membrane with chiral metal organic molecular cage as filler and preparation and application thereof 上海交通大学 2021-06-18 CN claimed
EP-3801880-A1 METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFS), COVALENT ORGANIC FRAMEWORKS (COFS) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFS), AND APPLICATIONS THEREOF Desiccant Rotors International Private Ltd. (IN) 2021-04-14 EP claimed
US-20200291045-A1 CONDUCTIVITY ENHANCEMENT OF MOFS VIA DEVELOPMENT OF MOFPOLYMER COMPOSITE MATERIAL KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2020-09-17 US claimed
CN-101781197-B Preparation method of chiral binaphthyl dicarboxylic acid UNIV ZHONGSHAN 2013-08-07 CN claimed
CN-101781197-A Preparation method of chiral binaphthyl dicarboxylic acid UNIV SUN YAT SEN 2010-07-21 CN claimed
JP-1066231-A None JP disclosed
CN-119409587-B Amino acid derivative of 2,2 '-binaphthyl-6, 6' -dicarboxylic acid, and preparation method and application thereof Renmin Hospital Of Wuhan University (hubei General Hospital) (CN) 2026-05-26 CN disclosed
US-20260138938-A1 SEPARATION METHOD DAIKIN INDUSTRIES, LTD. (JP) 2026-05-21 US disclosed
US-12516071-B2 Method for forming an electrically conductive metal organic framework composite KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-06 US disclosed
US-4252921-A IMAGES HAVING GOOD WEAR RESISTANCE EASTMAN KODAK COMPANY (US) 1981-02-24 US disclosed
US-4202785-A Polyesterionomers having utility in liquid electrographic developer compositions EASTMAN KODAK COMPANY (US) 1980-05-13 US disclosed
US-4098842-A AMINO-CONTAINING POLYOXYALKYLENE BASF WYANDOTTE CORPORATION (US) 1978-07-04 US disclosed
US-4052325-A LIQUID ELECTROGRAPHIC DEVELOPER COMPOSITION CONTAINING REDISPERSIBLE POLYESTER TONER AND PROCESS EASTMAN KODAK COMPANY (US) 1977-10-04 US disclosed
US-4045510-A POLYAMIDES, POLYESTERS, AND POLYURETHANES COATED WITH AN ANTISTATIC RENDERING POLYETHER BASF WYANDOTTE CORPORATION (US) 1977-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260138938-A1 SEPARATION METHOD DCX, FGB, TPR SOS1 4845/4885WDR5 3340/4885MEN1 2394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.